Chemotherapy |
Nanodiamond |
VitaminA analogs |
Enhanced the penetration into tumor |
[7,8] |
Doxorubicin |
Enhanced cytotoxicity |
Polymeric nanostructure |
Pirabucin |
Efficient delivery |
[9] |
Nanoliposome |
Vincristine |
Reduced side effects |
[10,11] |
Poly(L-aspartic acid sodium salt) nanoparticle |
Cisplatin |
Reduced side effects |
[12] |
Glutathione-responsive nanoparticle |
Cisplatin prodrug (Pt(IV)) |
Overcome drug resistance |
[13] |
Gene Therapy |
Mesoporous silica nanoparticles |
siRNA |
Enhanced targeting ability |
[14] |
Lipid nanoparticle |
[15] |
Chrysotile nanotubes |
circRNA |
Enhanced passive targeting ability |
[16] |
Exosome |
Enhanced active targeting ability |
[17,18] |
Immunotherapy |
MNC-ICG-NIG@SiO2 nanoparticles |
BCG |
Precisely controlled of drug release in tumor |
[19] |
Macrophage-derived exosome-mimetic nanovesicles |
PD-L1 inhibitor |
Blocking immunosuppression |
[20] |
Poly (propylglycolide-co-glycolide) nanoparticles |
Toll-like receptor 7/8 agonist |
Enhanced immune response |
[21] |
Phototherapy |
HSA-Ce6/NTZ/FCS nanoparticles |
Chlorin e6 |
Enhanced transmucosal delivery |
[22] |
Tumor-specific ligands |
Chlorin e6 |
Enhanced targeting ability |
[23] |
Mesoporous silica nanoparticles |
- |
Enhanced phototoxicity |
[24] |
Gold nanorods |
MnO2 |
Enhanced drug release in tumor microenvironment |
[25] |